These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 19060918)
1. Natural products as promising drug candidates for the treatment of hepatitis B and C. Wohlfarth C; Efferth T Acta Pharmacol Sin; 2009 Jan; 30(1):25-30. PubMed ID: 19060918 [TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection. Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464 [TBL] [Abstract][Full Text] [Related]
3. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues. Liu CJ J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625 [TBL] [Abstract][Full Text] [Related]
4. Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan. Hsieh MH; Yeh ML; Su TH; Liu TW; Huang CF; Huang CI; Wang SC; Huang JF; Dai CY; Kao JH; Chuang WL; Chen PJ; Liu CJ; Yu ML J Formos Med Assoc; 2018 Jun; 117(6):497-504. PubMed ID: 28694000 [TBL] [Abstract][Full Text] [Related]
5. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Liu CJ; Chuang WL; Lee CM; Yu ML; Lu SN; Wu SS; Liao LY; Chen CL; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Liu CH; Su WW; Lin CL; Jeng YM; Chen PJ; Chen DS Gastroenterology; 2009 Feb; 136(2):496-504.e3. PubMed ID: 19084016 [TBL] [Abstract][Full Text] [Related]
6. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure]. Vallet-Pichard A; Pol S Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection. Rautou PE; Asselah T; Saadoun D; Martinot M; Valla D; Marcellin P Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1019-22. PubMed ID: 16894318 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus. Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134 [TBL] [Abstract][Full Text] [Related]
9. Interferon and ribavirin treatment results of patients with HBV-HCV co-infection cured of childhood malignancies. Urganci N; Gulec S; Dogan S; Nuhoglu A Int J Infect Dis; 2006 Nov; 10(6):453-7. PubMed ID: 17000127 [TBL] [Abstract][Full Text] [Related]
10. Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirin. Potthoff A; Berg T; Wedemeyer H; Scand J Gastroenterol; 2009; 44(12):1487-90. PubMed ID: 19900055 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the treatment of HIV/HBV and HIV/HCV co-infection. Masgala A; Bonovas S; Nikolopoulos GK Mini Rev Med Chem; 2012 Aug; 12(9):890-904. PubMed ID: 22530578 [TBL] [Abstract][Full Text] [Related]
12. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers. Renou C; Cadranel JF; Pariente A; Pénaranda G; Bourlière M; Halfon P; Igual JP; Harafa A; Muller P; Bertrand JJ; Laugier R Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1235-7. PubMed ID: 18989147 [TBL] [Abstract][Full Text] [Related]
13. Perspectives on dual hepatitis B and C infection in Taiwan. Liu CJ; Chen PJ; Chen DS; Tseng TC; Kao JH J Formos Med Assoc; 2016 May; 115(5):298-305. PubMed ID: 26188762 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C Viruses and Biologics. Grewal P; Sanghera R Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153 [TBL] [Abstract][Full Text] [Related]
15. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus. Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Gene Therapy Coming to Age. Soriano V AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706 [TBL] [Abstract][Full Text] [Related]
17. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in antiviral agents: antiviral drug discovery for hepatitis viruses. Tanikawa K Curr Pharm Des; 2006; 12(11):1371-7. PubMed ID: 16611121 [TBL] [Abstract][Full Text] [Related]
19. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ; Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699 [TBL] [Abstract][Full Text] [Related]
20. [Diagnostic, clinical and therapeutic implications of viral hepatitides in HIV-infected patients]. Toro Rueda C; Ramos Blázquez B; Soriano Vázquez V Enferm Infecc Microbiol Clin; 2006 Oct; 24 Suppl 1():30-5. PubMed ID: 17125666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]